Letter: Reversal by physostigmine of clozapine-induced delirium.
D000328:Adult; D003024:Clozapine / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced*; D003984:Dibenzazepines / Q000009:adverse effects*; D004336:Drug Antagonism; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*
D003984:Dibenzazepines; D010830:Physostigmine; D003024:Clozapine